Hussain, Maha <br/><br/>
Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  04 2018 
 - 991-999 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2017.75.7310  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Androstenes--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Benzimidazoles--administration & dosage<br/>Biomarkers, Tumor<br/>DNA Repair<br/>Humans<br/>Male<br/>Middle Aged<br/>Molecular Targeted Therapy<br/>Neoplasm Metastasis<br/>Poly(ADP-ribose) Polymerase Inhibitors--administration & dosage<br/>Prednisone--administration & dosage<br/>Prostatic Neoplasms, Castration-Resistant--drug therapy<br/>Proto-Oncogene Proteins c-ets--genetics<br/>Receptors, Androgen--metabolism